Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Clinical, Laboratory, and Genetic Features of Erdheim-Chester Disease Patients from Two Reference Centers in a Developing Country

Antonio Adolfo Guerra Soares Brandão, MD, Giancarlo Fatobene, MD, Andre Abdo, MD, Luis Alberto de Padua Covas Lage, MD PhD, Israel Bendit, MD PhD, Luciana Nardinelli, MSc, Sheila Aparecida Coelho de Siqueira, MD PhD, Debora Levy, MSc, PhD, Juliana Pereira, MD PhD, Eduardo M Rego, MDPhD, Vanderson Rocha, MD PhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-142617

Published: 2020

Journal Articles

Splenic Marginal Zone Lymphoma (SMZL) - Outcomes, Prognostic Factors and Risk-Adapted Therapy in Resource-Poor Settings: Data from a Latin American Retrospective Cohort

Luis Alberto de Padua Covas Lage, MD PhD, Felipe Faganelli Caboclo dos Santos, MD, Kasys Meira Gervatauskas, MD, Debora Levy, MSc, PhD, Frederico Rafael Moreira, PhD, Samuel Campanelli Freitas Couto, PhD, Hebert Fabricio Culler, MSc, PhD, Renata Oliveira Costa, MDPhD, Vanderson Rocha, MD PhD, Juliana Pereira, MD PhD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-140807

Published: 2020

Journal Articles

GATA3 Gene - a Potential New Biomarker Associated with Adverse Outcomes in ALK1-Negative Anaplastic Large Cell Lymphoma: Preliminary Results from a Retrospective Cohort of 80 South American Cases of Nodal Peripheral T Lymphoma

Luis Alberto de Padua Covas Lage, MD PhD, Claudio Vinicius Brito, MD, Debora Levy, MSc, PhD, Hebert Fabricio Culler, MSc, PhD, Samuel Campanelli Freitas Couto, PhD, Lucas BO Alves, PhD, Maria C Zerbini, MD PhD Prof MD, Vanderson Rocha, MD PhD, Juliana Pereira, MD PhD

Blood (2020) 136 (Supplement 1): 38.

https://doi.org/10.1182/blood-2020-140833

Published: 2020

Journal Articles

Overexpression of the OCT-1 Gene Is a Biomarker Associated with Poor Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) - Data from a Retrospective Cohort from Latin America: Defining a Very High-Risk Clinical-Molecular Subgroup

Luis Alberto de Padua Covas Lage, MD PhD, Gisele Rodrigues Gouveia, PhD, Suzete Cleusa Ferreira, PhD, Sheila Aparecida Coelho de Siqueira, MD PhD, Abrahão Elias Hallack Neto, MD PhD, Renata Oliveira Costa, MDPhD, Juliana Pereira, MD PhD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-142715

Published: 2020

Journal Articles

Adult T-Cell Leukemia/Lymphoma: A Clinical and Epidemiological Analysis at the Medicine School of Sao Paulo University

Ana Costa Cordeiro, MD, Luis Alberto de Padua Covas Lage, MD, Renata Oliveira Costa, Debora Levy, Juliana Pereira, MD PhD

Blood (2015) 126 (23): 5091.

https://doi.org/10.1182/blood.V126.23.5091.5091

Published: 2015

Journal Articles

18 F-FDG PET Interim and Determination of Cellular Origin By Immunohistochemistry Identify a Group of Very Good Prognosis in Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Luis Alberto de Padua Covas Lage, MD, Renata Oliveira Costa, MD, Abrahão Elias Hallack Neto, MDPhD, Sheila Siqueira, PhD, Rodrigo Santucci, MD, Henrique Moura de Paula, MD, Juliana Pereira, PhD

Blood (2014) 124 (21): 3051.

https://doi.org/10.1182/blood.V124.21.3051.3051

Published: 2014

Journal Articles

Clinical Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Are Still Essential in the Rituximab Era

Luis Alberto de Padua Covas Lage, MD, Renata Oliveira Costa, Abrahão Elias Hallack Neto, MDPhD, Sheila Siqueira, PhD, Rodrigo Santucci, MD, Henrique Moura de Paula, MD, Juliana Pereira, PhD

Blood (2014) 124 (21): 3057.

https://doi.org/10.1182/blood.V124.21.3057.3057

Published: 2014

Journal Articles

Nodal Peripheral T-Cell Lymphoma – a Clinical and Epidemiological Analysis at Medicine School of Sao Paulo University

Luis Alberto de Padua Covas Lage, MD, Marianne Castro Goncalves, MD, Rodrigo Santucci, MD, Renata Oliveira Costa, MD, Debora Levy, Maria Claudia Zerbini, Juliana Pereira, PhD

Blood (2014) 124 (21): 1706.

https://doi.org/10.1182/blood.V124.21.1706.1706

Published: 2014

Journal Articles

CD4+ Lymphocytes in Asymptomatic HTLV-1 Carriers Present Cell Cycle Arrest in G0/G1-Phase

Mari Cleia Martins Rodrigues Ferreira, Renata Kikuchi Foltran, Rodrigo Santucci, MD, Luis Alberto de Padua Covas Lage, MD, Debora Levy, Juliana Pereira, PhD

Blood (2014) 124 (21): 5377.

https://doi.org/10.1182/blood.V124.21.5377.5377

Published: 2014

NARROW

Clinical, Laboratory, and Genetic Features of Erdheim-Chester Disease Patients from Two Reference Centers in a Developing Country

Splenic Marginal Zone Lymphoma (SMZL) - Outcomes, Prognostic Factors and Risk-Adapted Therapy in Resource-Poor Settings: Data from a Latin American Retrospective Cohort

GATA3 Gene - a Potential New Biomarker Associated with Adverse Outcomes in ALK1-Negative Anaplastic Large Cell Lymphoma: Preliminary Results from a Retrospective Cohort of 80 South American Cases of Nodal Peripheral T Lymphoma

Overexpression of the OCT-1 Gene Is a Biomarker Associated with Poor Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) - Data from a Retrospective Cohort from Latin America: Defining a Very High-Risk Clinical-Molecular Subgroup

Adult T-Cell Leukemia/Lymphoma: A Clinical and Epidemiological Analysis at the Medicine School of Sao Paulo University

18 F-FDG PET Interim and Determination of Cellular Origin By Immunohistochemistry Identify a Group of Very Good Prognosis in Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Clinical Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Are Still Essential in the Rituximab Era

Nodal Peripheral T-Cell Lymphoma – a Clinical and Epidemiological Analysis at Medicine School of Sao Paulo University

CD4+ Lymphocytes in Asymptomatic HTLV-1 Carriers Present Cell Cycle Arrest in G0/G1-Phase

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only